Gene Therapy as a Novel Pharmaceutical Intervention for Stroke

被引:16
作者
Ooboshi, Hiroaki [1 ]
机构
[1] Fukuoka Dent Coll, Dept Med, Sect Internal Med, Fukuoka, Japan
关键词
Gene transfer; gene therapy; vector; brain; ischemia; stroke; neurogenesis; stem cell; FOCAL CEREBRAL-ISCHEMIA; PROTECTS STRIATAL NEURONS; MESENCHYMAL STEM-CELLS; NITRIC-OXIDE SYNTHASE; BLOOD-BRAIN-BARRIER; TISSUE-PLASMINOGEN ACTIVATOR; ENDOTHELIAL GROWTH-FACTOR; TRANSFER IN-VIVO; ARTERY OCCLUSION; SUBARACHNOID HEMORRHAGE;
D O I
10.2174/138161211795164149
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cerebrovascular disease is the leading cause of death and disability in Japan and most Western countries. Gene transfer techniques may be applicable to the treatment of serious types of stroke, since several experimental studies have revealed the usefulness of gene therapy in the protection of neurons, reduction of infarct size and improvement of function. Prevention of vasospasm after subarachnoid hemorrhage is one of the best candidates for vascular gene therapy. Ischemia-induced apoptosis, inflammation, and derangement of neurovascular units can be targeted by the gene transfer approach. Recent studies have shown that promotion of neurogenesis and functional recovery may also be achieved by this strategy. Furthermore, a combination of stem cell therapy with gene transfer methods may be feasible. This review describes novel approaches for the treatment of stroke using gene transfer techniques.
引用
收藏
页码:424 / 433
页数:10
相关论文
共 94 条
[1]   Genetic medicine gets real [J].
Abbott, A .
NATURE, 2001, 411 (6836) :410-412
[2]   Neuronal replacement from endogenous precursors in the adult brain after stroke [J].
Arvidsson, A ;
Collin, T ;
Kirik, D ;
Kokaia, Z ;
Lindvall, O .
NATURE MEDICINE, 2002, 8 (09) :963-970
[3]   Neuroprotective effects of virally delivered HSPs in experimental stroke [J].
Badin, RA ;
Lythgoe, MF ;
van der Weerd, L ;
Thomas, DL ;
Gadian, DG ;
Latchman, DS .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2006, 26 (03) :371-381
[4]   Inflammatory mediators and stroke: New opportunities for novel therapeutics [J].
Barone, FC ;
Feuerstein, GZ .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1999, 19 (08) :819-834
[5]   Enhancement of expression of vascular endothelial growth factor after adeno-associated virus gene transfer is associated with improvement of brain ischemia injury in the gerbil [J].
Bellomo, M ;
Adamo, EB ;
Deodato, B ;
Catania, MA ;
Mannucci, C ;
Marini, H ;
Marciano, MC ;
Marini, R ;
Sapienza, S ;
Giacca, M ;
Caputi, AP ;
Squadrito, F ;
Calapai, G .
PHARMACOLOGICAL RESEARCH, 2003, 48 (03) :309-317
[6]   ATTENUATION OF STROKE SIZE IN RATS USING AN ADENOVIRAL VECTOR TO INDUCE OVEREXPRESSION OF INTERLEUKIN-1 RECEPTOR ANTAGONIST IN BRAIN [J].
BETZ, AL ;
YANG, GY ;
DAVIDSON, BL .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1995, 15 (04) :547-551
[7]   Molecular signatures of disease brain endothelia provide new sites for CNS-directed enzyme therapy [J].
Chen, Yong Hong ;
Chang, Michael ;
Davidson, Beverly L. .
NATURE MEDICINE, 2009, 15 (10) :1215-U145
[8]   Adenovirus-mediated gene transfer in vivo to cerebral blood vessels and perivascular tissue in mice [J].
Christenson, SD ;
Lake, KD ;
Ooboshi, H ;
Faraci, FM ;
Davidson, BL ;
Heistad, DD .
STROKE, 1998, 29 (07) :1411-1415
[9]   Gene therapy using SOD1 protects striatal neurons from experimental stroke [J].
Davis, Alexis S. ;
Zhao, Heng ;
Sun, Guo Hua ;
Sapolsky, Robert M. ;
Steinberg, Gary K. .
NEUROSCIENCE LETTERS, 2007, 411 (01) :32-36
[10]  
de Waal MR, 1991, J EXP MED, V174, P1209